Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants

Background: Patients with non-valvular atrial fibrillation (NVAF) need prophylactically antithrombotic therapies to reduce the risk of stroke. We hypothesized that the prognostic benefits of prophylactic antithrombotic therapies outweighed the bleeding risk among very elderly (≥85 years old) patient...

Full description

Bibliographic Details

Published in:	International Journal of Cardiology: Heart & Vasculature
Main Authors:	U Fan O, Tou Kun Chong, Yulin Wei, Bishow Paudel, Michael C. Giudici, Chi Wa Wong, Wai Kit Lei, Jian Chen, Wei Wu, Kan Liu
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Subjects:	Non-valvular atrial fibrillation Very elderly Non-vitamin K antagonist oral anticoagulants Bleeding Outcomes
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906722000586